• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌梅丸早期给药通过PI3K/Akt信号通路和氨基酸代谢抑制髓源性抑制细胞,以预防结肠炎相关结直肠癌。

Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.

作者信息

Lu Zhi-Hua, Ding Yang, Wang Yu-Ji, Chen Chen, Yao Xing-Ran, Yuan Xiao-Min, Bu Fan, Bao Han, Dong Yu-Wei, Zhou Qiao, Li Lu, Chen Tuo, Li Yang, Zhou Jin-Yong, Wang Qiong, Shi Guo-Ping, Jiang Feng, Chen Yu-Gen

机构信息

The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing 210029, China; No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China.

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing 210029, China.

出版信息

J Ethnopharmacol. 2024 Oct 28;333:118260. doi: 10.1016/j.jep.2024.118260. Epub 2024 Apr 27.

DOI:10.1016/j.jep.2024.118260
PMID:38685367
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Wumei Wan (WMW), a traditional Chinese medicine prescription, has been proved to be effective in treating Colitis-associated colorectal cancer (CAC), but it has not been proven to be effective in different stages of CAC.

AIM OF THE STUDY

The purpose of our study is to investigate the therapeutic effect and mechanism of WMW on the progression of CAC.

MATERIALS AND METHODS

Azioximethane (AOM) and dextran sulfate sodium (DSS) were used to treat mice for the purpose of establishing CAC models. WMW was administered in different stages of CAC. The presentative chemical components in WMW were confirmed by LC-MS/MS under the optimized conditions. The detection of inflammatory cytokines in the serum and colon of mice were estimated by qRT-PCR and ELISA. The changes of T cells and myeloid-derived suppressor cells (MDSCs) in each group were detected by flow cytometry. The metabolic components in serum of mice were detected by UPLC-MS/MS. Expression of genes and proteins were detected by eukaryotic transcriptomics and Western blot to explore the key pathway of WMW in preventing CAC.

RESULTS

WMW had significant effect on inhibiting inflammatory responses and tumors during the early development stage of CAC when compared to other times. WMW increased the length of mice's colons, reduced the level of IL-1β, IL-6, TNF-α in colon tissues, and effectively alleviated colonic inflammation, and improved the pathological damage of colon tissues. WMW could significantly reduce the infiltration of MDSCs in the spleen, increase CD4 T cells and CD8 T cells in the spleen of CAC mice, and effectively reform the immune microenvironment in CAC mice. Transcriptomics analysis revealed that 2204 genes had different patterns of overlap in the colon tissues of mice between control group, AOM + DSS group, and early administration of WMW group. And KEGG enrichment analysis showed that PI3K/Akt signaling pathway, ECM-receptor interaction, IL-17 signaling pathway, MAPK signaling pathway, pancreatic secretion, thermogenesis, and Rap1 signaling pathway were all involved. The serum metabolomics results of WMW showed that the metabolic compositions of the control group, AOM + DSS group and the early stage of WMW were different, and 42 differential metabolites with the opposite trends of changes were screened. The metabolic pathways mainly included pyrimidine metabolism, glycine, serine and threonine metabolism, tryptophan metabolism, and purine metabolism. And amino acids and related metabolites may play an important role in WMW prevention of CAC.

CONCLUSION

WMW can effectively prevent the occurrence and development of CAC, especially in the initial stage. WMW can reduce the immune infiltration of MDSCs in the early stage. Early intervention of WMW can improve the metabolic disorder caused by AOM + DSS, especially correct the amino acid metabolism. PI3K/Akt signaling pathway was inhabited in early administration of WMW, which can regulate the amplification and function of MDSCs.

摘要

民族药理学相关性

乌梅丸(WMW)是一种中药方剂,已被证明对治疗结肠炎相关结直肠癌(CAC)有效,但尚未被证明在CAC的不同阶段均有效。

研究目的

本研究旨在探讨乌梅丸对CAC进展的治疗作用及其机制。

材料与方法

使用氧化偶氮甲烷(AOM)和葡聚糖硫酸钠(DSS)处理小鼠以建立CAC模型。在CAC的不同阶段给予乌梅丸。在优化条件下通过液相色谱-串联质谱(LC-MS/MS)确认乌梅丸中的代表性化学成分。通过定量逆转录聚合酶链反应(qRT-PCR)和酶联免疫吸附测定(ELISA)评估小鼠血清和结肠中炎性细胞因子的检测情况。通过流式细胞术检测每组中T细胞和髓源性抑制细胞(MDSC)的变化。通过超高效液相色谱-串联质谱(UPLC-MS/MS)检测小鼠血清中的代谢成分。通过真核转录组学和蛋白质免疫印迹法检测基因和蛋白质的表达,以探索乌梅丸预防CAC的关键途径。

结果

与其他时期相比早,乌梅丸在CAC早期发育阶段对抑制炎症反应和肿瘤具有显著作用。乌梅丸增加了小鼠结肠长度,降低了结肠组织中白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)水平,有效减轻了结肠炎症,改善了结肠组织的病理损伤。乌梅丸可显著减少脾脏中MDSC的浸润,增加CAC小鼠脾脏中CD4 T细胞和CD8 T细胞,有效重塑CAC小鼠的免疫微环境。转录组学分析显示,对照组、AOM + DSS组和早期给予乌梅丸组小鼠的结肠组织中有2204个基因具有不同的重叠模式。京都基因与基因组百科全书(KEGG)富集分析表明,磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/Akt)信号通路、细胞外基质-受体相互作用、白细胞介素-17(IL-17)信号通路、丝裂原活化蛋白激酶(MAPK)信号通路、胰腺分泌、产热和Rap1信号通路均参与其中。乌梅丸的血清代谢组学结果表明,对照组、AOM + DSS组和乌梅丸早期组的代谢成分不同,并筛选出42种变化趋势相反的差异代谢物。代谢途径主要包括嘧啶代谢、甘氨酸、丝氨酸和苏氨酸代谢、色氨酸代谢和嘌呤代谢。氨基酸及相关代谢物可能在乌梅丸预防CAC中起重要作用。

结论

乌梅丸可有效预防CAC的发生和发展,尤其是在初始阶段。乌梅丸可在早期减少MDSC的免疫浸润。乌梅丸的早期干预可改善AOM + DSS引起的代谢紊乱,尤其是纠正氨基酸代谢。早期给予乌梅丸可抑制PI3K/Akt信号通路,该通路可调节MDSC的扩增和功能。

相似文献

1
Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer.乌梅丸早期给药通过PI3K/Akt信号通路和氨基酸代谢抑制髓源性抑制细胞,以预防结肠炎相关结直肠癌。
J Ethnopharmacol. 2024 Oct 28;333:118260. doi: 10.1016/j.jep.2024.118260. Epub 2024 Apr 27.
2
Huangqin tang alleviates colitis-associated colorectal cancer via amino acids homeostasisand PI3K/AKT/mtor pathway modulation.黄芩汤通过调节氨基酸稳态和 PI3K/AKT/mTOR 通路缓解结肠炎相关结直肠癌。
J Ethnopharmacol. 2024 Nov 15;334:118597. doi: 10.1016/j.jep.2024.118597. Epub 2024 Jul 19.
3
Mechanic evaluation of Wu-Mei-Pill on colitis-associated colorectal cancer: An integrated transcriptomics, metabolomics, and experimental validation study.乌梅丸对结肠炎相关结直肠癌的机制评估:一项整合转录组学、代谢组学和实验验证的研究
Phytomedicine. 2024 Jun;128:155509. doi: 10.1016/j.phymed.2024.155509. Epub 2024 Mar 2.
4
Wu Mei Wan attenuates CAC by regulating gut microbiota and the NF-kB/IL6-STAT3 signaling pathway.乌梅丸通过调节肠道微生物群和 NF-κB/IL6-STAT3 信号通路来减轻 CAC。
Biomed Pharmacother. 2020 May;125:109982. doi: 10.1016/j.biopha.2020.109982. Epub 2020 Feb 25.
5
Madecassic acid alleviates colitis-associated colorectal cancer by blocking the recruitment of myeloid-derived suppressor cells via the inhibition of IL-17 expression in γδT17 cells.羟基积雪草苷通过抑制γδT17细胞中IL-17的表达,阻断髓源性抑制细胞的募集,从而减轻结肠炎相关的结直肠癌。
Biochem Pharmacol. 2022 Aug;202:115138. doi: 10.1016/j.bcp.2022.115138. Epub 2022 Jun 11.
6
Wumei Wan attenuates angiogenesis and inflammation by modulating RAGE signaling pathway in IBD: Network pharmacology analysis and experimental evidence.乌梅丸通过调节 RAGE 信号通路抑制 IBD 的血管生成和炎症:网络药理学分析及实验证据。
Phytomedicine. 2023 Mar;111:154658. doi: 10.1016/j.phymed.2023.154658. Epub 2023 Jan 12.
7
Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota.安康育阳汤通过调控 PPAR 信号通路及影响宿主与肠道菌群代谢稳态抑制实验性结肠炎相关癌变。
J Ethnopharmacol. 2024 May 23;326:117995. doi: 10.1016/j.jep.2024.117995. Epub 2024 Feb 28.
8
GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.GNAI1 和 GNAI3 通过阻断 IL6 信号和下调 GNAI2 的表达来减少小鼠的结肠炎相关肿瘤发生。
Gastroenterology. 2019 Jun;156(8):2297-2312. doi: 10.1053/j.gastro.2019.02.040. Epub 2019 Mar 2.
9
Wumei Pill Ameliorates AOM/DSS-Induced Colitis-Associated Colon Cancer through Inhibition of Inflammation and Oxidative Stress by Regulating S-Adenosylhomocysteine Hydrolase- (AHCY-) Mediated Hedgehog Signaling in Mice.乌梅丸通过调节 S-腺苷同型半胱氨酸水解酶(AHCY)介导的 Hedgehog 信号通路抑制炎症和氧化应激改善 AOM/DSS 诱导的结肠炎相关结直肠癌在小鼠中的作用。
Oxid Med Cell Longev. 2022 Jul 26;2022:4061713. doi: 10.1155/2022/4061713. eCollection 2022.
10
Treatment of ulcerative colitis with Wu-Mei-Wan by inhibiting intestinal inflammatory response and repairing damaged intestinal mucosa.乌美溴铵治疗溃疡性结肠炎通过抑制肠道炎症反应和修复受损的肠道黏膜。
Phytomedicine. 2022 Oct;105:154362. doi: 10.1016/j.phymed.2022.154362. Epub 2022 Jul 30.

引用本文的文献

1
Sphingosine-1-phosphate alleviates colitis by regulating macrophage polarization and PI3k-Akt signaling.鞘氨醇-1-磷酸通过调节巨噬细胞极化和PI3k-Akt信号传导来减轻结肠炎。
Front Immunol. 2025 Jul 21;16:1622094. doi: 10.3389/fimmu.2025.1622094. eCollection 2025.
2
Qingjie Fuzheng Granule prevents colitis-associated colorectal cancer by inhibiting abnormal activation of NOD2/NF-B signaling pathway mediated by gut microbiota disorder.清解扶正颗粒通过抑制肠道微生物群紊乱介导的NOD2/NF-κB信号通路异常激活来预防结肠炎相关结直肠癌。
Chin Herb Med. 2025 Apr 3;17(3):500-512. doi: 10.1016/j.chmed.2025.04.001. eCollection 2025 Jul.
3
Determination of Multiple Active Components in Mume Fructus by UPLC-MS/MS.
超高效液相色谱-串联质谱法测定乌梅中多种活性成分
Metabolites. 2025 May 6;15(5):312. doi: 10.3390/metabo15050312.
4
Influence of gut microbial metabolites on tumor immunotherapy: mechanisms and potential natural products.肠道微生物代谢产物对肿瘤免疫治疗的影响:作用机制与潜在天然产物
Front Immunol. 2025 Feb 24;16:1552010. doi: 10.3389/fimmu.2025.1552010. eCollection 2025.
5
Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review).小RNA在炎症性肠病及相关结直肠癌中的新作用(综述)
Int J Mol Med. 2025 Feb;55(2). doi: 10.3892/ijmm.2024.5474. Epub 2024 Dec 20.
6
Coagulation factor II thrombin receptor as a promising biomarker in breast cancer management.凝血因子II凝血酶受体作为乳腺癌管理中有前景的生物标志物。
Open Life Sci. 2024 Dec 6;19(1):20221001. doi: 10.1515/biol-2022-1001. eCollection 2024.
7
Research progress of DNA methylation in colorectal cancer (Review).结直肠癌中 DNA 甲基化的研究进展(综述)。
Mol Med Rep. 2024 Sep;30(3). doi: 10.3892/mmr.2024.13278. Epub 2024 Jul 4.